Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Stereotactic Radiotherapy|Immunotherapy|Breast Cancer
Interventions: DRUG: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)|DRUG: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)
Sponsor: Shengjing Hospital